Navigation Links
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Date:8/21/2008

WAYNE, N.J. and EMERYVILLE, Calif., Aug. 21 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the companies have begun enrolling patients in the STORM Sorafenib as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma trial. The randomized, double-blind, placebo-controlled Phase 3 study is evaluating Nexavar(R) (sorafenib) tablets as adjuvant treatment, which is treatment following surgery or local radiation, for patients with hepatocellular carcinoma (HCC), or primary liver cancer.

"Nexavar is the only systemic therapy with proven efficacy and tolerability in HCC across multiple patient populations," said Dimitris Voliotis, MD, vice president, Nexavar Clinical Development, Bayer HealthCare Pharmaceuticals. "Liver cancer is the third largest global cancer killer worldwide and there is a significant need for new therapies that can be used at all stages in the course of the disease to delay disease progression and prolong life."

In addition, the U.S. Food and Drug Administration (FDA) has completed a Special Protocol Assessment (SPA) for the STORM trial. An SPA is a written agreement on the design and size of a clinical trial intended to form the basis for a new drug application.

Phase 3 Trial Design

The international multicenter study is expected to enroll approximately 1,100 patients and will include patients who have received surgical resection or local ablation. The study will look at whether providing oral Nexavar in the adjuvant setting delays the time to recurrence and increases overall survival. The primary endpoint of the study is recurrence free survival. Secondary endpoints include overall survival, ti
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCarePharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
2. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
6. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
7. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
8. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... TAMPA, Fla. , July, 29  2014 ... it has hired John Bournas as ... who announced plans to leave the Society last ... with extensive competencies in the healthcare association industry ... to the Society a clear vision for the ...
(Date:7/29/2014)... NASHVILLE, Tenn. and NEW YORK ... and member of the executive management team of Caremark ... of PBM365 Media ( www.pbm365.com ).  PBM365 is the ... and unbiased reporting, insight, analysis and opinion on ... PBM365 will provide insightful and timely coverage of, ...
(Date:7/29/2014)... July 29, 2014 McGraw-Hill Education Professional, a ... science, technical, and medical communities, has announced the launch ... mobile application of the world-renowned medical education platform. ... AccessMedicine App , available for download onto all iOS ... able to gain access to valuable AccessMedicine ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3Drew Crawford Announces Launch of PBM365 Media 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3
... SAN FRANCISCO, Jan. 6, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... the company,s chairman and chief executive officer, is scheduled to ... in San Francisco, CA on Thursday, January 13th at 11:30 ... To access the live audio webcast or the subsequent archived ...
... Jan. 6, 2011 Genesis ... a biotechnology company developing targeted cancer therapies, announces that CEO ... Showcase™ 2011 conference on Wednesday, January 12, 2011, at 9:45 ... Parc 55 Wyndham San Francisco – Union Square. ...
Cached Medicine Technology:Genesis Biopharma to Present at 2011 Biotech Showcase Conference 2
(Date:7/29/2014)... 29, 2014 The Board of Governors of ... Hart LLP ’s Connie Akridge to serve as ... as President of the Foundation. Akridge served as President of ... a partner at Holland & Hart in Las Vegas, providing ... matters to insurance and healthcare clients for more than 25 ...
(Date:7/29/2014)... Many people complain about their dependence on eyeglasses. For ... put on glasses to see their clock or make their ... be dissatisfied with their vision even when using their glasses ... driving, especially at night due to glare. They can ... see the TV, sew or cross stitch, or read fine ...
(Date:7/29/2014)... Springs, LA (PRWEB) July 29, 2014 ... holiday across the United States usually celebrated throughout that ... recently though, those summer days now mark the start ... in crashes involving teen drivers. In 2012 nearly ... during the period from Memorial Day to Labor Day. ...
(Date:7/29/2014)... Avenidas is always looking for ... again, the non-profit agency is doing just that with the ... , This event gives seniors the opportunity to learn about ... will be a variety of fun activities, including a Tai ... and artists. In addition, there will be food tastings, courtesy ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Summer is here, and ... means enjoying a hike, swimming in a pool or laying out ... for fleas and ticks. The Puppy Store is here to help ... summer months. , It’s almost impossible to completely keep fleas and ... to minimize the chances of their pets coming into contact with ...
Breaking Medicine News(10 mins):Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2Health News:Avenidas Hosts Third Annual Successful Aging Celebration 2Health News:Protect Dogs From Fleas and Ticks During the Summer 2
... approach to the ... thoracolumbar spine, MARQUETTE, Mich., ... of the Cross-Fuse(TM) Lateral,Option System. The Cross-Fuse is Pioneer,s latest addition ... of the Los Angeles Orthopaedic Institute in,Sherman Oaks, California says, "The ...
... The Paul Bear Bryant,Awards committee of the American ... Coach Barry Switzer has been named the,2009 winner of ... the Lifetime Achievement Award at the Paul Bear,Bryant College ... Hyatt Regency Hotel in Houston. The award recognizes excellence ...
... from ground-breaking scientific trials of new interventional techniques ... - Transcatheter Cardiovascular Therapeutics the global annual ... will present a variety of new data that ... Featured trials will focus on the safety and ...
... Mach One,Corporation (Pink sheets: MNCN) ("Purchaser" or the ... letter of intent dated,September 26, 2008 related to a ... to acquire all of the outstanding common shares of,the ... completion of due,diligence by the Purchaser, the execution of ...
... Disabled Veterans, WASHINGTON, Sept. 29 The ... are supporting VA,s,newest rehabilitative event for injured veterans, ... fortunate to have such gracious sponsors to bring ... Dr. James B. Peake, Secretary of,Veterans Affairs. "For ...
... enrollment season,throughout corporate America is rapidly approaching, and ... decisions about their employee,benefit coverage for next year. ... emphasis on personal health behaviors as well as ... and programs, according to,benefit consultants at Watson Wyatt ...
Cached Medicine News:Health News:Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System 2Health News:Barry Switzer to Receive Paul 'Bear' Bryant Lifetime Achievement Award 2Health News:TCT update: press conference schedule announced for TCT 2Health News:TCT update: press conference schedule announced for TCT 3Health News:Mach One Corporation Enters Letter of Intent 2Health News:Mach One Corporation Enters Letter of Intent 3Health News:Watson Wyatt Identifies Trends for Benefits Open Enrollment Season 2Health News:Watson Wyatt Identifies Trends for Benefits Open Enrollment Season 3
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
These backbiters enable simple access to the anterior horn of the meniscus....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... were developed in surgeon's desire to have ... an instrument with the strength to maneuver ... the bending or breaking. Arthrotek Hand Instruments ... to the surgeon's hand. This new generation ...
Medicine Products: